These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18663007)

  • 1. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.
    Diaz MH; Shaver CM; King JD; Musunuri S; Kazzaz JA; Hauser AR
    Infect Immun; 2008 Oct; 76(10):4414-21. PubMed ID: 18663007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia.
    Diaz MH; Hauser AR
    Infect Immun; 2010 Apr; 78(4):1447-56. PubMed ID: 20100855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.
    Schulert GS; Feltman H; Rabin SD; Martin CG; Battle SE; Rello J; Hauser AR
    J Infect Dis; 2003 Dec; 188(11):1695-706. PubMed ID: 14639541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.
    Pestrak MJ; Chaney SB; Eggleston HC; Dellos-Nolan S; Dixit S; Mathew-Steiner SS; Roy S; Parsek MR; Sen CK; Wozniak DJ
    PLoS Pathog; 2018 Feb; 14(2):e1006842. PubMed ID: 29394295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
    Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
    Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.
    Howell HA; Logan LK; Hauser AR
    mBio; 2013 Mar; 4(2):e00032-13. PubMed ID: 23481600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.
    Koh AY; Priebe GP; Ray C; Van Rooijen N; Pier GB
    Infect Immun; 2009 Dec; 77(12):5300-10. PubMed ID: 19805527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.
    Mueller-Ortiz SL; Drouin SM; Wetsel RA
    Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia.
    Rhein LM; Perkins M; Gerard NP; Gerard C
    Am J Respir Cell Mol Biol; 2008 Apr; 38(4):401-6. PubMed ID: 17975174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
    Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
    Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia.
    Gates KL; Howell HA; Nair A; Vohwinkel CU; Welch LC; Beitel GJ; Hauser AR; Sznajder JI; Sporn PH
    Am J Respir Cell Mol Biol; 2013 Nov; 49(5):821-8. PubMed ID: 23777386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.
    Song Z; Zhang J; Zhang X; Li D; Wang H; Xu X; Xu W; Yin Y; Cao J
    J Infect Dis; 2015 May; 211(10):1616-27. PubMed ID: 25489003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
    Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
    Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo.
    Allen L; Dockrell DH; Pattery T; Lee DG; Cornelis P; Hellewell PG; Whyte MK
    J Immunol; 2005 Mar; 174(6):3643-9. PubMed ID: 15749902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.
    Veesenmeyer JL; Howell H; Halavaty AS; Ahrens S; Anderson WF; Hauser AR
    Infect Immun; 2010 Aug; 78(8):3346-57. PubMed ID: 20479080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
    Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
    J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol-(3,4,5)-Trisphosphate Induces Phagocytosis of Nonmotile Pseudomonas aeruginosa.
    Demirdjian S; Hopkins D; Sanchez H; Libre M; Gerber SA; Berwin B
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detrimental Effect of Type I IFNs During Acute Lung Infection With
    Pylaeva E; Bordbari S; Spyra I; Decker AS; Häussler S; Vybornov V; Lang S; Jablonska J
    Front Immunol; 2019; 10():2190. PubMed ID: 31572395
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
    Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ
    J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.